HEI Therapeutics ApS: Financial statements 2024
CVR: 42613207
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
HEI Therapeutics ApS (CVR 42613207) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 1,762,455 and a net result of DKK -12,890,414 compared with DKK -381,736 the year before. That is a decrease of 55.2% compared with the year before. Equity in the 2024 report amounted to DKK -13,516,567. The company had 5 employees in the financial year.
- Gross Profit
- DKK 1,762,455
- Profit/Loss
- DKK -12,890,414
- Equity
- DKK -13,516,567
- Total Assets
- DKK 2,359,216
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 1.8M | -12.9M | -13.5M | 5 |
| 2023 | - | 3.9M | -382K | -626K | 5 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
HEI Therapeutics ApS has published its annual report for 2023. Gross profit came to DKK 3,935,885, and the net result was DKK -381,736.
About HEI Therapeutics ApS
HEI Therapeutics ApS was a Danish company of the type Anpartsselskab based in København N, founded in 2021. The company has been dissolved on 30 June 2026. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 1 employee (2025). In 2024, the company reported a gross profit of DKK 1,762,455 and a net result of DKK -12,890,414 compared with DKK -381,736 the year before. Equity in the 2024 report amounted to DKK -13,516,567.